Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Neuropharmacology

• Publication date

  1990-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0028-3908(90)90022-JPMID 2385332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm

  2004cited by this paper
• Discriminative stimulus properties of nicotine: Further evidence for mediation at a cholinergic receptor

  2004cited by this paper
• Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats

  2004cited by this paper
• Characterization of the receptor mediating the nicotine discriminative stimulus

  2004cited by this paper
• Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine

  2004cited by this paper
• Role of training dose in discrimination of nicotine and related compounds by rats

  2004cited by this paper
• Locomotor activity in rats after administration of nicotinic agonists intracerebrally

  1990cited by this paper
• 8-Substituted Xanthines As Phosphodiesterase Inhibitors - Conformation-Dependent Lipophilicity and Structure-Activity-Relationships

  1989cited by this paper
• Primary cholinergic and indirect dopaminergic mediation of behavioural effects of nicotine.

  1989cited by this paper
• Relations between structure and nicotine‐like activity: X‐ray crystal structure analysis of (−)−cytisine and (−)−lobeline hydrochloride and a comparison with (−)−nicotine and other nicotine‐like compounds

  1989cited by this paper
• The comparative binding characteristics of nicotinic ligands and their pharmacology.

  1988cited by this paper
• High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.

  1988cited by this paper
• Lipophilicity measurement of nicotinates by reversed-phase high-performance liquid chromatography : Differences in retention behaviour, but similarities of log kw values, in methanol-water and acetonitrile-water eluents

  1987cited by this paper
• Lipophilicity measurements of protonated basic compounds by reversed-phase high-performance liquid chromatography : I. Relationship between capacity factors and the methanol concentration in methanol-water eluents

  1985cited by this paper
• Nicotine action on rat colon.

  1981cited by this paper
• Stereospecific nicotine receptors on rat brain membranes.

  1980cited by this paper
• pH Dependence of Blood‐Brain Barrier Permeability to Lactate and Nicotine

  1979cited by this paper
• Discriminative Stimulus Properties of Nicotine and Nicotine-Related Compounds1

  1978cited by this paper
• Some studies on cytisine and its methylated derivatives

  1969cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper
• Emetic action of nicotine and lobeline.

  1957cited by this paper

• Molecular mechanisms of Lobeline-mediated inhibition of lysozyme amyloidogenesis: A synergistic approach using biophysical and cheminformatics techniques.

  2025cites this paper
• Cytisine: State of the art in pharmacological activities and pharmacokinetics.

  2024cites this paper
• Lobeline: A multifunctional alkaloid modulates cholinergic and glutamatergic activities

  2023cites this paper
• New medications development for smoking cessation

  2023cites this paper
• Neurobiological Mechanisms of Nicotine Reward and Aversion

  2022cites this paper
• Liquid Chromatography on the Different Methods for the Determination of Lipophilicity: An Essential Analytical Tool in Medicinal Chemistry

  2022cites this paper
• Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions

  2021cites this paper
• Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity

  2021cites this paper
• Recent Developments In Novel Antidepressants Targeting Ô±4ÔÂ22-Nicotinic Acetylcholine Receptors

  2021cites this paper
• Preclinical and clinical research on the discriminative stimulus effects of nicotine.

  2020cites this paper
• Comparison of Various Chromatographic Systems for Analysis of Cytisine in Human Serum, Saliva and Pharmaceutical Formulation by HPLC with Diode Array, Fluorescence or Mass Spectrometry Detection

  2019cites this paper
• Cytisine for nicotine addiction treatment: A review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.

  2019cites this paper
• Research Progress in Pharmacological Effects of Cytisine

  2019influential citation
• NAChR α4β2 subtype and their relation with nicotine addiction, cognition, depression and hyperactivity disorder.

  2019cites this paper
• VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine).

  2018cites this paper
• Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons".

  2018cites this paper
• Discovery and development of varenicline for smoking cessation

  2018cites this paper
• Natural Products in Addiction Treatment

  2017cites this paper
• Medications for alcohol use disorders: An overview

  2017cites this paper
• Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels

  2017influential citation
• Development of Antidepressant Drugs Through Targeting α4β2-Nicotinic Acetylcholine Receptors

  2016cites this paper
• TOWARDS AN UNDERSTANDING OF PHARMACOLOGICALLY INDUCED INTRACELLULAR CHANGES IN NICOTINIC ACETYLCHOLINE RECEPTORS: A FLUORESCENCE MICROSCOPY APPROACH

  2016cites this paper
• New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

  2016cites this paper
• A Review of the Organic Synthesis and Medicinal Applications of the Natural Product Cytisine

  2016cites this paper
• The Neuropharmacology of Nicotine Dependence

  2015cites this paper
• Agonist and antagonist effects of cytisine in vivo.

  2015influential citation
• Pharmacokinetics of cytisine, an α4 β2 nicotinic receptor partial agonist, in healthy smokers following a single dose.

  2015cites this paper
• hypoxiaresponses of newborn rats to intermittent Threshold levels of maternal nicotine impairing

  2015cites this paper
• The role of mesoaccumbens dopamine in nicotine dependence.

  2015cites this paper
• Methamphetamine-Like Discriminative-Stimulus Effects of Nicotinic Agonists

  2014influential citation
• Characterization Of Imidacloprid Resistance In The House Fly, Musca Domestica.

  2014cites this paper
• Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors

  2014cites this paper
• Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids

  2013cites this paper
• Antidepressant-like effects of lobeline in mice: behavioral, neurochemical, and neuroendocrine evidence.

  2013influential citation
• Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

  2013cites this paper
• The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats.

  2013influential citation
• Peganine isolated from Anisotes trisulcus as a smoking deterrent and anorexigenic agent

  2012cites this paper
• The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

  2012cites this paper
• Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.

  2012cites this paper
• Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.

  2012cites this paper
• Quantitative Determination of Lobeline Hydrochloride in Rabbit Plasma by LC–MS–MS and Its Application

  2011cites this paper
• Nicotinic receptor agonist-induced salivation and its cellular mechanism in parotid acini of rats.

  2011cites this paper
• Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice.

  2011influential citation
• Drug development in the light of translational science: shine or shade?

  2011cites this paper
• PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES

  2011influential citation
• Neonicotinoid insecticides: historical evolution and resistance mechanisms.

  2010cites this paper
• Effect of cytisine on some brain and hepatic biochemical parameters in spontaneously hypertensive rats

  2010cites this paper
• Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

  2010cites this paper
• Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

  2010cites this paper
• Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

  2010cites this paper
• Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients

  2010cites this paper
• Fatal cytisine intoxication and analysis of biological samples with LC-MS/MS.

  2009cites this paper
• Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats.

  2009influential citation
• Emerging drugs for the treatment of tobacco dependence

  2009cites this paper
• Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.

  2009influential citation
• Emerging drugs for the treatment of tobacco dependence.

  2009cites this paper
• Recognising nicotine: the neurobiological basis of nicotine discrimination.

  2009cites this paper
• Chapter 4 Case History: Chantix™/Champix™ (Varenicline Tartrate), a Nicotinic Acetylcholine Receptor Partial Agonist as a Smoking Cessation Aid

  2009cites this paper
• Nicotinic plant poisoning

  2009cites this paper
• Cytisine for smoking cessation: a research agenda.

  2008cites this paper
• Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.

  2008cites this paper
• THE EFFECTS OF LOBELINE ON METHAMPHETAMINE-INDUCED CONDITIONED PLACE PREFERENCE AND DOPAMINERGIC ALTERATIONS IN THE NUCLEUS ACCUMBENS SHELL

  2008cites this paper
• Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

  2008cites this paper
• Smoking cessation therapy with varenicline

  2008cites this paper
• Chemical medicine: novel 10-substituted cytisine derivatives with increased selectivity for alpha4beta2 nicotinic acetylcholine receptors.

  2007cites this paper
• Chemical Medicine: Novel 10‐Substituted Cytisine Derivatives with Increased Selectivity for α4β2 Nicotinic Acetylcholine Receptors

  2007cites this paper
• Cytisine—from Ethomedical use to the Development as a Natural Alternative for Smoking Cessation

  2007cites this paper
• Lobelane decreases methamphetamine self-administration in rats.

  2007cites this paper
• Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.

  2007cites this paper
• The exceptional hydrogen-bond properties of neutral and protonated lobeline.

  2007cites this paper
• Total Synthesis of the Lupin Alkaloid Cytisine: Comparison of Synthetic Strategies and Routes

  2007cites this paper
• Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine.

  2006cites this paper
• Treatment of Nicotine Dependence: Toward a Partial Solution

  2006cites this paper
• Lobeline augments and inhibits cocaine-induced hyperactivity in rats.

  2006cites this paper
• SYNTHESIS AND EVALUATION OF PYRIDINIUM DERIVATIVES AS CENTRAL NERVOUS SYSTEM NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

  2006cites this paper
• Varenicline: An α4β2 Nicotinic Acetylcholine Receptor Partial Agonist as an Aid to Smoking Cessation

  2006cites this paper
• Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice.

  2006cites this paper
• Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.

  2006cites this paper
• Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

  2006cites this paper
• Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

  2005cites this paper
• From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research.

  2005cites this paper
• Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task

  2005cites this paper
• A recursive-partitioning model for blood–brain barrier permeation

  2005cites this paper
• Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats

  2005cites this paper
• In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine

  2005cites this paper
• Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

  2005cites this paper
• In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.

  2005cites this paper
• Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity.

  2004cites this paper
• Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters

  2004influential citation
• Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.

  2004cites this paper
• Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats.

  2003cites this paper
• Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.

  2003cites this paper
• Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats

  2003influential citation
• NON-CONVENTIONAL EFFECTS OF NICOTINIC AGONISTS AND MONOAMINE UPTAKE BLOCKERS IN THE CENTRAL NERVOUS SYSTEM

  2003cites this paper
• Cytisine derivatives as high affinity nAChR ligands: synthesis and comparative molecular field analysis.

  2002cites this paper
• Fetal exposure to nicotine does not alter the core temperature response of 7- to 8-week-old rats to intracerebroventricular administration of PGE(1).

  2002cites this paper
• A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

  2002cites this paper
• A specific anti‐aggressive effect of repeatedly administered lobeline

  2002cites this paper
• Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia.

  2001cites this paper
• Differential Effect of Nicotinic Agonists on the [3H]Norepinephrine Release from Rat Hippocampal Slices

  2001cites this paper